Groowe Groowe / Newsroom / QNTM
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

QNTM News

Quantum Biopharma Ltd. Class B Subordinate Voting Shares

Pomerantz LLP Advises Shareholders of Class Action Against Quantum Biopharma Ltd. – QNTM

accessnewswire.com
QNTM

Pomerantz LLP Advises Shareholders of Class Action Filing Involving Quantum Biopharma Ltd. – QNTM

accessnewswire.com
QNTM

QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Shareholders Have Opportunity to Lead Class Action Lawsuit!

accessnewswire.com
QNTM

Pomerantz LLP Advises of Securities Class Action Involving Quantum Biopharma Ltd. – QNTM

accessnewswire.com
QNTM

Pomerantz LLP Advises Shareholders of Class Action Filing Against Quantum Biopharma Ltd. – QNTM

accessnewswire.com
QNTM

Pomerantz LLP Advises of Securities Class Action Against Quantum Biopharma Ltd. – QNTM

accessnewswire.com
QNTM

QNTM STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!

accessnewswire.com
QNTM

Pomerantz LLP Advises Shareholders of Class Action Against Quantum Biopharma Ltd. – QNTM

accessnewswire.com
QNTM

Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

globenewswire.com
QNTM

CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines - QNTM

prnewswire.com
QNTM